Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study
ConclusionLetermovir was generally well tolerated, and the data support its use for the prevention of CMV disease/infection in adult Japanese KTRs.Trial registrationClinicalTrials.gov NCT04129398.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cytomegalovirus | Japan Health | Kidney Transplant | Kidney Transplantation | Study | Transplant Surgery | Transplants | Urology & Nephrology | USA Health